Thromoembolism. Vascular complications following infusion, transfusion and therapeutic injection
Conditions
Interventions
Intervention 1: Subcutaneous injection of Enoxaparine (6000 IU or 4000 IU) over 30 seconds. Intervention 2: Subcutaneous injection of Enoxaparine (6000 IU or 4000 IU) over 10 seconds.
Treatment - Drugs
Subcutaneous injection of Enoxaparine (6000 IU or 4000 IU) over 30 seconds
Subcutaneous injection of Enoxaparine (6000 IU or 4000 IU) over 10 seconds
Sponsors
Vice-chancellor for Research, Bushehr University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: age greater than 18 years; newly admitted patients; orientation to person/place/time/situation; able to rate the pain perceived at the injection site; Exclusion criteria: coagulation disorders (thrombocytopenia and PT, PTT, INR, LFT impaired); Presence of scar tissue, any skin lesion or unilateral senso neural obvious defects or damage and abdominal trauma at the injection areas; receiving other anticoagulants such as warfarin and heparin
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bruising. Timepoint: 48 hours and 72 hours after injection. Method of measurement: Area of bruising in squared milimeter by an special software. | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain intensity. Timepoint: Immediately after injection. Method of measurement: A numerical scale from 0 to 10. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAzar Dadain
Bushehr University of Medical Sciences
Outcome results
None listed